AGP Picks
View all

The New Jersey Post: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The New Jersey Post.

Press releases published on November 2, 2026

Strategic Alliance USA Announces “Vote Informed” Campaign Focused on Sanctuary Policies and Public Spending
Femometer Introduces SoMind, Connecting Ring Air S to an AI Health Ecosystem
SELECCIÓN Consulting Launches First Autonomous AMS - Runs Inside Your SAP: AI Agents Resolve Routine Tickets in Minutes
Vornado Announces Third Quarter 2026 Financial Results
Hain Celestial Announces Fiscal 2027 First Quarter Earnings Results Conference Call and Webcast
Top Rack Technology to Unveil Six Innovative Solar Mounting Solutions at RE+ 2026 in Las Vegas
Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares
New Jersey Fourth Graders Invited to Enter  Fun Things to Do Instead of Drugs Bookmark Contest
NJ Proper Unveils Research Results: How the Convenience Economy Is Changing What Homebuyers Expect in 2026
CMI Media Group Promotes Sargi Mann to Chief Strategy Officer to Drive Integrated Strategic Rigor and Client Growth
Alexander’s Announces Third Quarter Financial Results
Change Agents Joins Meta's Muse Developer Program to Expand Distribution of its AI-Powered Applications, Catch-Up and Beacon
Edible Garden CEO Jim Kras to Discuss Innovation and Diversification at 2026 CEAg World Conference & Expo
New Jersey Handicap Parking Placards: HandicapMD Introduces Eligibility and Application Guide
Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026
UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective
CorMedix Therapeutics Provides Business Update, Reaffirms 2026 Total Revenue Guidance, and Reports Third Quarter Cash Position
Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The New Jersey Post

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.